Legal & General Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Legal & General Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,758,060	Closed	-$323M	–	3533
2021 Q2	$323M	Buy	1,758,060 +315,094	+22%	+$54.1M	0.11%	208
2021 Q1	$221M	Sell	1,442,966 -23,976	-2%	-$3.71M	0.08%	283
2020 Q4	$229M	Buy	1,466,942 +39,940	+3%	+$5.13M	0.09%	250
2020 Q3	$163M	Sell	1,427,002 -2,320	-0.2%	-$250K	0.07%	297
2020 Q2	$160M	Buy	1,429,322 +42,151	+3%	+$4.48M	0.08%	288
2020 Q1	$125M	Buy	1,387,171 +55,613	+4%	+$5.46M	0.07%	286
2019 Q4	$144M	Buy	1,331,558 +54,648	+4%	+$5.84M	0.07%	322
2019 Q3	$125M	Sell	1,276,910 -4,349	-0.3%	-$490K	0.07%	327
2019 Q2	$168M	Sell	1,281,259 -7,530	-0.6%	-$971K	0.09%	255
2019 Q1	$174M	Buy	1,288,789 +257,964	+25%	+$32.1M	0.1%	235
2018 Q4	$100M	Buy	1,030,825 +70,099	+7%	+$8.29M	0.08%	280
2018 Q3	$134M	Buy	960,726 +13,631	+1%	+$1.71M	0.1%	244
2018 Q2	$118M	Sell	947,095 -44,469	-4%	-$5.2M	0.09%	251
2018 Q1	$111M	Sell	991,564 -35,874	-3%	-$4.29M	0.08%	268
2017 Q4	$123M	Sell	1,027,438 -18,961	-2%	-$2.31M	0.09%	254
2017 Q3	$147M	Buy	1,046,399 +21,643	+2%	+$2.94M	0.11%	216
2017 Q2	$125M	Buy	1,024,756 +21,915	+2%	+$2.55M	0.1%	230
2017 Q1	$122M	Buy	1,002,841 +39,061	+4%	+$5.04M	0.1%	227
2016 Q4	$118M	Buy	963,780 +11,913	+1%	+$1.46M	0.11%	217
2016 Q3	$117M	Buy	951,867 +3,310	+0.3%	+$426K	0.12%	207
2016 Q2	$111M	Buy	948,557 +28,037	+3%	+$3.98M	0.12%	208
2016 Q1	$128M	Buy	920,520 +35,267	+4%	+$5.18M	0.14%	165
2015 Q4	$169M	Sell	885,253 -11,175	-1%	-$1.95M	0.19%	125
2015 Q3	$140M	Buy	896,428 +52,444	+6%	+$9.57M	0.17%	144
2015 Q2	$153M	Buy	843,984 +73,438	+10%	+$12.7M	0.18%	137
2015 Q1	$134M	Buy	770,546 +4,327	+0.6%	+$783K	0.16%	154
2014 Q4	$142M	Sell	766,219 -23,180	-3%	-$4.3M	0.17%	141
2014 Q3	$131M	Sell	789,399 -33,928	-4%	-$5.57M	0.16%	154
2014 Q2	$129M	Buy	823,327 +7,338	+0.9%	+$1.16M	0.15%	165
2014 Q1	$124M	Buy	815,989 +8,771	+1%	+$1.39M	0.15%	163
2013 Q4	$107M	Sell	807,218 -7,699	-0.9%	-$924K	0.13%	186
2013 Q3	$94.7M	Sell	814,917 -7,749	-0.9%	-$850K	0.12%	194
2013 Q2	$75.9M	Buy	+822,666	New	+$79.3M	0.1%	224

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return